PMID- 33041976 OWN - NLM STAT- PubMed-not-MEDLINE LR - 20201013 IS - 1664-2295 (Print) IS - 1664-2295 (Electronic) IS - 1664-2295 (Linking) VI - 11 DP - 2020 TI - Tuberous Sclerosis Complex as Disease Model for Investigating mTOR-Related Gliopathy During Epileptogenesis. PG - 1028 LID - 10.3389/fneur.2020.01028 [doi] LID - 1028 AB - Tuberous sclerosis complex (TSC) represents the prototypic monogenic disorder of the mammalian target of rapamycin (mTOR) pathway dysregulation. It provides the rational mechanistic basis of a direct link between gene mutation and brain pathology (structural and functional abnormalities) associated with a complex clinical phenotype including epilepsy, autism, and intellectual disability. So far, research conducted in TSC has been largely neuron-oriented. However, the neuropathological hallmarks of TSC and other malformations of cortical development also include major morphological and functional changes in glial cells involving astrocytes, oligodendrocytes, NG2 glia, and microglia. These cells and their interglial crosstalk may offer new insights into the common neurobiological mechanisms underlying epilepsy and the complex cognitive and behavioral comorbidities that are characteristic of the spectrum of mTOR-associated neurodevelopmental disorders. This review will focus on the role of glial dysfunction, the interaction between glia related to mTOR hyperactivity, and its contribution to epileptogenesis in TSC. Moreover, we will discuss how understanding glial abnormalities in TSC might give valuable insight into the pathophysiological mechanisms that could help to develop novel therapeutic approaches for TSC or other pathologies characterized by glial dysfunction and acquired mTOR hyperactivation. CI - Copyright (c) 2020 Zimmer, Broekaart, Gruber, van Vliet, Muhlebner and Aronica. FAU - Zimmer, Till S AU - Zimmer TS AD - Department of (Neuro)Pathology, Amsterdam Neuroscience, Amsterdam University Medical Centers, University of Amsterdam, Amsterdam, Netherlands. FAU - Broekaart, Diede W M AU - Broekaart DWM AD - Department of (Neuro)Pathology, Amsterdam Neuroscience, Amsterdam University Medical Centers, University of Amsterdam, Amsterdam, Netherlands. FAU - Gruber, Victoria-Elisabeth AU - Gruber VE AD - Department of Pediatrics and Adolescent Medicine, Medical University of Vienna, Vienna, Austria. FAU - van Vliet, Erwin A AU - van Vliet EA AD - Department of (Neuro)Pathology, Amsterdam Neuroscience, Amsterdam University Medical Centers, University of Amsterdam, Amsterdam, Netherlands. AD - Swammerdam Institute for Life Sciences, Center for Neuroscience, University of Amsterdam, Amsterdam, Netherlands. FAU - Muhlebner, Angelika AU - Muhlebner A AD - Department of (Neuro)Pathology, Amsterdam Neuroscience, Amsterdam University Medical Centers, University of Amsterdam, Amsterdam, Netherlands. FAU - Aronica, Eleonora AU - Aronica E AD - Department of (Neuro)Pathology, Amsterdam Neuroscience, Amsterdam University Medical Centers, University of Amsterdam, Amsterdam, Netherlands. AD - Stichting Epilepsie Instellingen Nederland (SEIN), Heemstede, Netherlands. LA - eng PT - Journal Article PT - Review DEP - 20200917 PL - Switzerland TA - Front Neurol JT - Frontiers in neurology JID - 101546899 PMC - PMC7527496 OTO - NOTNLM OT - astrocyte OT - epilepsy OT - epileptogenesis OT - glia OT - mammalian target of rapamycin (mTOR) OT - microglia OT - oligodendrocyte OT - tuberous sclerosis (TSC) EDAT- 2020/10/13 06:00 MHDA- 2020/10/13 06:01 PMCR- 2020/09/17 CRDT- 2020/10/12 05:28 PHST- 2020/06/07 00:00 [received] PHST- 2020/08/06 00:00 [accepted] PHST- 2020/10/12 05:28 [entrez] PHST- 2020/10/13 06:00 [pubmed] PHST- 2020/10/13 06:01 [medline] PHST- 2020/09/17 00:00 [pmc-release] AID - 10.3389/fneur.2020.01028 [doi] PST - epublish SO - Front Neurol. 2020 Sep 17;11:1028. doi: 10.3389/fneur.2020.01028. eCollection 2020.